Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Crohn’s Disease: AZD7798 PET Study
We are examining how different doses of the drug AZD7798 are taken up in the body of patients with Crohn’s disease. This study aims to provide insights into the drug's effects on this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Karolinska University Hospital
Fas-1 enheten, M62
Huddinge, Sweden
Sponsor: AstraZeneca AB
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.